Alignment Healthcare (NASDAQ:ALHC) CEO John Kao Sells 298,000 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John Kao sold 298,000 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $16.89, for a total value of $5,033,220.00. Following the transaction, the chief executive officer owned 1,508,641 shares of the company’s stock, valued at approximately $25,480,946.49. The trade was a 16.49% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Alignment Healthcare Price Performance

Shares of NASDAQ:ALHC traded down $0.11 during mid-day trading on Wednesday, reaching $18.27. The stock had a trading volume of 31,183,205 shares, compared to its average volume of 3,775,435. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 1.56. The company has a market cap of $3.78 billion, a P/E ratio of 203.00, a price-to-earnings-growth ratio of 2.40 and a beta of 1.26. Alignment Healthcare, Inc. has a 1 year low of $11.63 and a 1 year high of $23.87. The business’s 50 day moving average price is $19.15 and its 200 day moving average price is $19.48.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.04. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The business had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.22 billion. During the same quarter last year, the business posted ($0.05) EPS. The firm’s revenue for the quarter was up 33.3% compared to the same quarter last year. Research analysts expect that Alignment Healthcare, Inc. will post 0.19 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Raymond James Financial set a $22.00 price target on shares of Alignment Healthcare in a research report on Thursday, May 7th. JPMorgan Chase & Co. lifted their price objective on shares of Alignment Healthcare from $23.00 to $26.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Wall Street Zen upgraded shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday. UBS Group upped their target price on shares of Alignment Healthcare from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Friday, May 1st. Finally, TD Cowen increased their price target on shares of Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a report on Friday, January 16th. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, Alignment Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $24.60.

Institutional Investors Weigh In On Alignment Healthcare

Several institutional investors have recently made changes to their positions in the company. Allworth Financial LP boosted its stake in shares of Alignment Healthcare by 8.9% during the fourth quarter. Allworth Financial LP now owns 6,917 shares of the company’s stock valued at $137,000 after purchasing an additional 566 shares during the period. State of Alaska Department of Revenue increased its stake in Alignment Healthcare by 6.0% in the 4th quarter. State of Alaska Department of Revenue now owns 11,296 shares of the company’s stock worth $223,000 after buying an additional 636 shares during the period. Integrated Wealth Concepts LLC increased its stake in Alignment Healthcare by 6.3% in the 3rd quarter. Integrated Wealth Concepts LLC now owns 11,230 shares of the company’s stock worth $196,000 after buying an additional 665 shares during the period. Parallel Advisors LLC lifted its holdings in Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after buying an additional 773 shares in the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH boosted its position in Alignment Healthcare by 2.3% in the 3rd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 37,752 shares of the company’s stock valued at $659,000 after buying an additional 844 shares during the period. Institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.